Search clinical trials for: Bladder Cancer

Total 88709 results

MedImmune LLC

Terminated

Trial of MEDI-507 in CD2-Positive Lymphoproliferative Disease

Lymphoproliferative Disorders

United States
VA Puget Sound Health Care System
Dr. Gregory Merrick; Theragenics Corporation

Unknown

I-125 Versus Pd-103 for Medium Risk Prostate Cancer

Prostate Cancer

United States
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle

Sarcoma of Pelvis

France
Point Therapeutics

Completed

Study of Talabostat and Cisplatin in Advanced Melanoma

Melanoma | Skin Cancer

United States
Point Therapeutics

Completed

Study of Talabostat in Advanced Melanoma

Melanoma | Skin Cancer

United States
Point Therapeutics

Completed

Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer

Lung Cancer

United States
Point Therapeutics

Terminated

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Carcinoma, Non-Small-Cell Lung | Lung Cancer | Neoplasms, Lung | Neoplasms, Pulmonary

United States
Point Therapeutics

Terminated

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Carcinoma, Non-Small Cell Lung

United States
Point Therapeutics

Terminated

Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas

Adenocarcinoma | Neoplasm Metastasis | Pancreatic Cancer

United States
University of Roma La Sapienza

Completed

Systematic Pelvic Lymphadenectomy Versus no Lymphadenectomy in Clinical Stage I-II Endometrial Cancer

Endometrial Cancer
Urological Sciences Research Foundation
Allergan

Unknown

This is a Prospective, Randomized, Double-Blind Study Comparing Intravesical Injection of Botox® to Placebo. (BTX0621)

Overactive Bladder

United States
MediQuest Therapeutics

Completed

Lab Study of MQX-503 in Treatment of Raynaud's

Raynaud Disease | Raynaud Disease Secondary to Scleroderma | Raynaud Secondary to Other Autoimmune Disease

United States
Skane University Hospital
Swedish Cancer Society; Europe Against Cancer (European Union Directorate General...

Completed

Randomized Controlled Trial of Human Papillomavirus Testing in Primary Cervical Cancer Screening (SWEDESCREEN)

Cervical Cancer | Cervical Intraepithelial Neoplasia

Sweden
Eli Lilly and Company

Completed

A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment

Breast Cancer | Ovarian Cancer | Endometrial Cancer

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Effexor XR for Major Depression.

Depression

Japan
Eli Lilly and Company

Completed

Urge Incontinence Bladder Overactivity Study

Urinary Incontinence

United States, Australia, Canada
Finnish Breast Cancer Group
Sanofi; Hoffmann-La Roche; AstraZeneca

Completed

Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer

Breast Cancer

Finland
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Mackay Memorial Hospital; China Medical... and other collaborators

Unknown

A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer

Pancreatic Cancer

Taiwan
Rambam Health Care Campus

Unknown

Safety and Applicability Study of a Novel Heat Flow Sensor Unit for Measuring Urinary Bladder Capacity

Overactive Bladder | Enuresis | Urge Urinary Incontinence | Self Clean Intermittent Catheterization

Israel
Eli Lilly and Company

Completed

Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have Failed Prior Platinum-Based Chemotherapy

Ovarian Neoplasms | Primary Peritoneal Cancer

Spain, Germany, Belgium, United Kingdom
Groupe Francophone des Myelodysplasies

Unknown

Darbepoetin Alpha in Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes

France
Hadassah Medical Organization

Unknown

Radiation Induced Atherosclerosis in Breast Cancer Patients

Breast Cancer | Atherosclerosis | Abnormalities, Radiation-Induced

Israel
Pharmacyclics LLC.

Completed

Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors

Breast Neoplasms | Lung Neoplasms | Prostatic Neoplasms | Ovarian Neoplasms

United States
Innovive Pharmaceuticals

Terminated

INNO-105 in Patients With Solid Tumors

Tumors

United States
Trans Tasman Radiation Oncology Group
Cancer Council New South Wales

Completed

SuperDEX Trial (Comparison of Two Doses of Dexamethasone for Malignant Spinal Cord Compression Treated by Radiotherapy).

Spinal Cord Compression From Neoplasm Metastasis

Australia
Sunesis Pharmaceuticals

Completed

Initial Safety Assessment of SNS-595 for the Treatment of Solid Tumors.

Neoplasms

United States
Sunesis Pharmaceuticals

Completed

Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors

Neoplasms

United States
Pharmacyclics LLC.

Terminated

Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer

Head and Neck Cancer | Oropharynx Cancer | Larynx Cancer | Hypopharynx Cancer

United States
Seattle Cancer Treatment and Wellness Center

Unknown

Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer

Stage III Pancreatic Cancer | Stage IVA Pancreatic Cancer | Stage IVB Pancreatic Cancer | Adenocarincoma of Pancreas

United States
Tampere University

Completed

Casodex/Zoladex Biomarkers in Localised Prostate Cancer

Prostate Cancer

Finland
Pharmacyclics LLC.

Completed

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

Carcinoma, Non-Small-Cell Lung | Brain Neoplasms | Metastases, Neoplasm

United States, France, Belgium, Germany, Canada, Netherlands, Austria, Australia
Mountain Area Health Organization Center

Unknown

Randomized Controlled Trial of Bladder Flap vs.None

Cesarean Delivery Procedures

United States
Novacea
Aventis Pharmaceuticals

Completed

Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
Pfizer

Completed

Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer

Kidney Neoplasms

United States
Pfizer

Completed

A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer

Breast Neoplasms | Carcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Pancreatic Neoplasms

United States
Tel-Aviv Sourasky Medical Center
Rabin Medical Center; Kaplan Medical Center

Unknown

Evaluation of NiTi Shape Memory End-to-End Compression Anastomosis Ring (CAR) for Compression Anastomosis in Anterior Resection

Colorectal Cancer

Israel
Pfizer

Completed

A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer

Breast Neoplasms

United States, Canada, Ireland, Italy, Sweden, Belgium, France, Spain, United Kingdom
University of Alberta, Physical Education

Completed

Physical Activity Promotion in Breast Cancer Survivors

Breast Cancer

Canada
Eli Lilly and Company

Completed

Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer.

Non-Small-Cell Lung Carcinoma

United States
Tehran University of Medical Sciences

Completed

Comparison of 2 Cefazolin Prophylactic Protocol in Laryngectomy Patients

Laryngeal Cancer

Iran, Islamic Republic of
Radboud University Medical Center

Completed

The Role of CT-PET-MRI Image Fusion in Determining Radiation Treatment Volumes of Head-and-Neck Cancer Patients

Head and Neck Neoplasms

Netherlands
Ontario Clinical Oncology Group (OCOG)
Pfizer

Completed

Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients

Venous Thromboembolism | Brain Tumors

United States, Canada, Australia, Italy
Grupo Gallego de Cancer de Pulmon

Unknown

Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

Spain
Massachusetts General Hospital
Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center

Completed

Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization.

Lymphoma | Multiple Myeloma | Acute Myelogenous Leukemia

United States
University of Saskatchewan
Sanofi

Terminated

Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal Cancers

Platinum Sensitive Relapsed Ovarian Cancer

Canada
Gunma University

Completed

Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer

Carcinoma, Non-Small-Cell Lung
University of Michigan Rogel Cancer Center

Terminated

Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood

Myelodysplastic Syndromes | Leukemia | Multiple Myeloma | Lymphoma, Low-Grade | Lymphoma, Non-Hodgkin's

United States
University Health Network, Toronto

Completed

Minimum Dose CT Post Lung Biopsy

Lung Cancer

Canada
University of Aarhus

Unknown

MRI in Staging Ovarian Cancer Using MRI Contrast Agent

Ovarian Cancer
Oncology Specialties, Alabama

Terminated

Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma

Metastatic Breast Cancer

United States

Search clinical trials for: Bladder Cancer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations